Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
20.50
-1.70 (-7.66%)
Nov 21, 2024, 4:00 PM EST - Market open
Oruka Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$43.60
Upside
+112.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +119.51% | Oct 31, 2024 |
| Stifel | Stifel | Strong Buy Initiates $49 | Strong Buy | Initiates | $49 | +139.02% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +119.51% | Oct 7, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $44 | Buy | Initiates | $44 | +114.63% | Sep 17, 2024 |
| Leerink Swann | Leerink Swann | Buy Initiates $44 | Buy | Initiates | $44 | +114.63% | Sep 17, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +95.12% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Initiates $40 | Buy | Initiates | $40 | +95.12% | Sep 4, 2024 |